!-- Google Tag Manager -->
The Interplay of Obesity and Psoriatic Diseases: Inflammatory Pathways, Emerging Treatments, and Interdisciplinary Strategies for Improved Patient Outcomes
Mar 22

The Interplay of Obesity and Psoriatic Diseases:...

 

map
Click on the Map to see the location
  • return-icon-whiteReturn to Summit Events




    The Interplay of Obesity and Psoriatic Diseases: 
    Inflammatory Pathways, Emerging Treatments, and Interdisciplinary Strategies for Improved Patient Outcomes

    Registration link: Click here hands icon purp

    icon pur peopl

    Join us for an insightful webinar exploring the intricate relationship between obesity and psoriatic diseases (PsD), and the groundbreaking potential of GLP-1 receptor agonists (RAs) in transforming care. 


    Obesity not only exacerbates the risk and severity of PsD, but also perpetuates a cycle of chronic inflammation and metabolic dysfunction, worsening patient health and outcomes.


    While a multidisciplinary approach to obesity management is crucial, new GLP-1 receptor agonists (RAs) have demonstrated benefits not only in weight management but also in reducing inflammation. Given this, several recent and ongoing clinical trials are investigating GLP-1 RAs in the setting of obesity and psoriatic diseases.


    In this webinar, leading rheumatology and endocrinology experts will navigate through the impact and overlap of obesity, inflammation, and PsD; key clinical data on GLP-1 RAs; and practical insights on the introduction of these novel therapies into rheumatology care. 


    Plus, you can earn 1.5 CME/MOC! Register now for FREE. 


    How To Participate 

    This is a virtual event, so please register following these 3 easy steps:

    1. Go to our registration page and register for the Summit.
    2. Save your registration email with your link and login information.
    3. Log in to the virtual meeting app during the Summit to participate!

    The companion virtual meeting app allows you to watch the Summit livestream, review the program agenda and faculty information, send questions, participate in polling questions, complete pre- and post-activity surveys, and find information to claim CME/MOC credits!


    Please note: you must register and complete the poll/survey questions in the virtual meeting app to claim your free CME credits.

    Watch Party Locations – Coming Soon!
     

    Summit Details

    1

    Date: March 22nd, 2025  

    Time: 12:00 PM – 15:20 EST

    1

    Location: Virtual with Community Watch Parties*

    * Join a Local Watch Party to network with your colleagues and enjoy a memorable meal while watching the presentations. Locations will be added over time; you can register now as a virtual attendee and modify your registration to pick a Watch Party later.

    icon pur peopl

    Chairs:

    • Grace C. Wright, MD, PhD, FACR
      AWIR President and Founder
    • Priya Reddy, MD, FACR
      AWIR Secretary and Treasurer
    User Image - Dr.Wright User Image -Priya Reddy
    icon pur peopl

    Speakers: TBD


    Program


    12:00-12:10 - Welcome Remarks

    12:10-12:40  - Educational Symposium

    12:40-14:10 -  Accredited Session (1.5 CME/MOC)

    14:10-14:25 
    - Break

    14:25-14:40 
    - Roundtable

    14:40-15:10 
    - Product Theater

    15:10-15:20 
    - Closing Remarks

     


    CME Session Information


    Learning Objectives:

    • Assess the underlying and overlapping inflammatory pathways in obesity and psoriatic diseases (PsD). 
    • Recognize the impact of obesity and weight loss on disease-specific and patient-reported outcomes in patients with PsD. 
    • Evaluate new and emerging treatment options for obesity based on mechanisms of action, efficacy and safety data, and patient eligibility. 
    • Apply current evidence, patient factors, and interdisciplinary strategies to make individualized treatment decisions for patients with obesity and PsD.   

      icon pur peopl

    Agenda: 

    • Assess the underlying and overlapping inflammatory pathways in obesity and psoriatic diseases (PsD)
    • Recognize the impact of obesity and weight loss on disease-specific and patient-reported outcomes in patients with PsD.
    • Evaluate new and emerging treatment options for obesity based on mechanisms of action, efficacy and safety data, and patient eligibility.
    • Apply current evidence, patient factors, and interdisciplinary strategies to make individualized treatment decisions for patients with obesity and PsD.

     


    Registration link: Click here hands icon purp

  • Category
    Summits
  • Date & Time
    Mar 22 2025 at 12:00 - Mar 22 2025 at 15:30
  • Location & full address
    Virtual with Community Watch Parties*
;